Apoptosis Promoters
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/120,275, filed Dec 5, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 7,767,684 | Apoptosis Promoters In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 7,642,260 | Apoptosis Promoters In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 7,973,161 | Apoptosis Promoters In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 8,614,318 | Apoptosis Promoters In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,045,420 | BCL-2-Selective Apoptosis-Inducing Agents for the Treatment of Cancer and Immune Diseases In force · Medium confidence | AbbVie Inc. | In force | Medium confidence | ||
| US 9,072,748 | BCL-2-Selective Apoptosis-Inducing Agents for the Treatment of Cancer and Immune Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,073,855 | BCL-2 Selective Apoptosis-Inducing Agents for the Treatment of Cancer and Immune Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,125,913 | BCL-2-Selective Apoptosis-Inducing Agents for the Treatment of Cancer and Immune Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 9,315,488 | BCL-2-Selective Apoptosis-Inducing Agents for the Treatment of Cancer and Immune Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| US 8,586,754 | BCL-2-Selective Apoptosis-Inducing Agents for the Treatment of Cancer and Immune Diseases In force · High confidence | AbbVie Inc. | In force | High confidence | ||
| 6 more patents in this group · Pro | ||||||
10 of 16 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 16, including 5 expired and 3 expiring within the 18 months from Nov 17, 2026.
11 of these are in force and held by AbbVie Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.